Could this anti-aging dog pill lead to one for you too?

Summary

---

Short Wave: "Could this anti-aging dog pill lead to one for you too?"

Date: July 7, 2026
Host: Regina Barber
Guest: Ross Andersen (Staff Writer, The Atlantic)
Length in Transcript: ~12 min (content segment: 00:21–11:39)

---

Episode Overview

This episode explores the science behind a new anti-aging pill developed for dogs by the biotech company Loyal. Host Regina Barber and guest Ross Andersen discuss the biological mechanisms targeted by the drug, how it may improve both lifespan and healthspan for dogs, and the potential implications for human aging. The episode blends accessible science, personal stories, and touches of humor for a general audience.

---

Key Discussion Points & Insights

1. Origins of the Dog Longevity Pill

[00:28–01:24]

• Ross Andersen introduces Loyal’s founder, Celine Hallowa, whose deep connection with animals while growing up inspired her quest to help pets live longer, healthier lives.
• Quote:
  "She told me her family had like 15 dogs and cats, and most of them were strays. And she fell in love, actually, with a horse that lived locally. He lived with a ratchet cowboy, is how she described it to me." – Ross [01:08]

2. Scientific Background & Inspiration

[01:28–03:50]

• Hallowa’s exposure to neuro-oncology in college made her passionate about combating aging and disease.
• Other life-extension breakthroughs (roundworms, C. elegans) are discussed:
  • Genetics and metabolism as routes to longer lifespans—Cynthia Kenyon's work on doubling worm lifespan in the 1990s is referenced.
• Quote:
  "A brilliant scientist named Cynthia Kenyon lengthened, doubled the lifespan actually of C. Elegans, the round worm." – Ross [03:21]

3. How Loyal’s Pill Works: Targeting Metabolism

[04:00–07:12]

• The pill acts on metabolic pathways, specifically by improving insulin sensitivity in aging dogs.
• Reference to the Purina study: underfeeding Labradors by 25% increased lifespan by 15%.
• Mechanistic explanation:
  • Aging dogs develop reduced insulin sensitivity, needing to pump more insulin, which causes inflammation and accelerates aging.
  • Loyal’s pill boosts tissue sensitivity—"like little Paul Revere’s telling those tissue systems, listen for the insulin." – Ross [06:54]
• Memorable Analogy:
  "The loyal pill helps to restore that insulin sensitivity... the particles kind of go all throughout the body, like little Paul Revere’s telling those tissue systems, listen for the insulin. Listen for the insulin. Wow." – Ross [06:44]

4. Regulatory Status & Timeline

[07:12–08:16]

• Loyal has conditional FDA approval for efficacy and safety, with only manufacturing hurdles left.
• Anticipated release for dogs: "early next year."
• Clinical trials for full approval will take 4–5 more years.

5. Why Not Cats?

[08:16–08:53]

• Feline longevity pill startups exist, but dogs are the initial focus because it’s easier to get them to take a daily pill.
• Humorous Moment:
  "Dogs are better at taking pills. I thought it was going to be because cats live longer, but I think you’re right." – Regina [08:46]

6. Pills, Flavor, and Dog Preferences

[08:53–09:45]

• Loyal’s pill needed to taste good and be accepted over time, not just once.
• 20 taste-tester dogs were used; one picky dog even urinated on an unappetizing flavor.
• Final flavor: beef.

7. Personal Touch: Would Ross Give It to His Dog?

[09:45–10:27]

• Ross’s dog, Forrest, is four years old—eligible for the pill at age ten, when more definitive trial results are expected.
• Ross plans to give Forrest the pill if it passes all tests.
• Quote:
  "I want him around longer." – Ross [10:25]

---

Notable Quotes & Memorable Moments

• On Dog-Human Similarities in Aging:
  "They get the same cancers and are treated with the same chemotherapies." – Ross [02:25]

• On Insulin Sensitivity Mechanism:
  "As dogs age, their insulin sensitivity gets a lot worse... the loyal pill helps to restore that insulin sensitivity." – Ross [05:47–06:40]

• On Dogs as Pill Recipients:
  "Dogs are better at taking pills, but they’re not perfect... one of them spat out one of the flavors they didn’t like and ended up peeing on it." – Ross [09:11–09:35]

• On Age Verification in Dog Trials:
  "Some of the dogs needed Facebook photos... people don’t have their dog birth certificate, so they had to put screenshots of their Facebook posts showing... them being like, I got a new puppy, you know, and it’s time stamped." – Ross [11:06]

---

Timestamps for Key Segments

• 00:28–01:24 — Introduction: Loyal's inspiration & founder’s background
• 01:28–03:50 — Previous life-extension science; worms to dogs
• 04:00–07:12 — Metabolism, insulin, and the pill’s mechanism of action
• 07:12–08:16 — FDA process and anticipated rollout for dogs
• 08:16–08:53 — Why not cats?
• 08:53–09:45 — Getting the taste right; beef flavor wins
• 09:45–10:27 — Would Ross give the pill to his own dog?
• 11:06–11:39 — Fun bonus: proof-of-age for dogs via Facebook

---

Final Reflections

• The episode ends by drawing a link between canine anti-aging science and possible future human benefits.
• Listeners are encouraged to share the episode with friends who love their dogs.
• Humorous, warm moments punctuate the science, keeping the tone friendly and accessible.

---

Transcript

[A]

This message comes from U.S. bank. Simplify how you do business with business essentials. A powerful combination of no monthly maintenance fee, checking and card payment processing. Deposit products are offered by U.S. bank National association member FDIC.

[B]

You're listening to Short Wave from NPR.

[A]

False.

[C]

False.

[A]

Good boy.

[B]

This is Ross Anderson, a staff writer at the Atlantic. And as you heard, he has a dog, Forrest.

[C]

He's delighted to be on the show. Now he thinks that, like, I've called him over to play fetch.

[B]

Ross called Forrest over because he was the inspiration for Ross's reporting on a company called Loyal. They're working on a new drug to fight against every dog lover's greatest fear, inevitably losing their pet to time. The hope is this new pill will extend the lives of dogs. And the vision all started in the rural outskirts of Austin, Texas, where Loyal's founder, Celine Hollowa grew up. Her whole childhood, she was surrounded by animals, forming deep, loving bonds with a lot of them.

[C]

She told me her family had like 15 dogs and cats, and most of them were strays. And she fell in love, actually, with a horse that lived locally. He lived with a ratchet cowboy, is how she described it to me.

[B]

That bond with animals was on her mind as she went off to college.

[C]

She worked at a neuro oncology lab and so got to kind of see just the horror, the cosmic horror, really, of brain cancer very close up. And it had a profound effect upon her.

[B]

Loyal's drug is still working through the FDA's approval process, but their preliminary results show it could extend your dog's life a year or even two. And just as importantly, their health.

[C]

No one wants to tack on another two years of those, like, kind of heartbreaking final months of a dog's life when they're struggling with, you know, the very worst health issues. This is intended to not only extend their lives, but also, like, make kind of the back half of their life much more pleasant for them, kind of in a whole body way.

[B]

And as exciting as this pill is on its own for dog lovers, it also serves a much bigger purpose to be an important pit stop on the quest to eventually lengthen human lives.

[C]

Because we have certain things in common in our body plan, but also they age in many of the same ways that we do. They get the same cancers and are treated with the same chemotherapies.

[B]

So today on the show, why a boon for man's best friend may be a boon for humanity itself. Down the line, we get into how this pill works for dogs and why that same mechanism may be a blueprint for a pill for you one day. Plus why scientists haven't gotten the job done for cats yet. I'm Regina Barber and you're listening to Shortwave, the science podcast from npr. Okay, Ross, you're here to tell us about a new pill that may make our dogs live longer and healthier. But this isn't the first time that science has successfully made organisms live longer. What are some other times or ways scientists have extended life?

[C]

Yeah, well, sorry to report that it starts with worms. Starting in the 1990s, a brilliant scientist named Cynthia Kenyon lengthened, doubled the lifespan actually of C. Elegans, the round worm.

[B]

Oh, I love C. Elegans. All of my biology friends work on those.

[C]

Yeah, yeah, they're kind of like the classic sort of easy to mess with in the lab. And in this case it really benefited them because they got their lifespan doubled.

[B]

Doubled.

[A]

Wow.

[B]

What is their normal lifespan?

[C]

Yeah, C. Elegans, you know, it's not a long lived animal. Right. It only lives about two to three weeks. And so by doubling it, I think, you know, she got it up to a month, which is something.

[B]

Right. So Ross, I'm interested in knowing like in this specific case with Loyal's pill for dogs, how does it work biologically?

[C]

Yeah, well, it actually goes at the metabolism, which may be counterintuitive, but there was a striking study done in the 1990s by Purina that the dog food company where they took 50 Labrador puppies and they split them up and they fed half of them 25% less. Sorry to those dogs. But in the end they ended up living like a full 15% longer. Just like really, really dramatic result. And so that was a big clue that life extension in general might be attacked through the metabolism and that particularly you could do it through dogs. Now when you put that together with the fact that that technique that had extended the lives of roundworms actually attacked the insulin receptors of those roundworms. So that also was a metabolic pathway. Similarly, there is accumulating evidence that GLP1s could act in a kind of life, extending way across the whole body. And those also are metabolic drugs. And so, yeah, I think there's just, you know, it's not just Celine and Loyal. I think in the life extension industry in general, metabolism is hot right now. There's just a real sense that this could be the key to, you know, significantly extending not just dogs lives, but potentially our lives.

[B]

This is surprising. Like when I think about aging and dying, I usually think about heart failure or something happening to my brain. Or something. How exactly does the pill target metabolism, and how does that help with aging?

[C]

Okay, so the first thing to know is that as dogs age, their insulin sensitivity gets a lot worse. So, like, in a healthy young dog, as soon as, you know, they wolf down some kibble, their blood sugar goes up, and their body releases just, like, a tiny bit of insulin. And all the tissue around their body that absorbs glucose, you know, senses that insulin, that, like, tiny, tiny pulse of it and gobbles up the glucose. Right. As they get older, those tissue systems around the body, they get bad at listening for that insulin. And so as a result, the dog has to pump more and more insulin throughout its body in order to get to have that glucose get absorbed. And that excess insulin causes inflammation all across the body and aggravates a lot of its aging.

[B]

Okay.

[C]

And so the loyal pill helps to restore that insulin sensitivity. And the way it does it is once the dog has, like, the kibble and its blood sugar spikes, this pill dissolves. The particles kind of go all throughout the body. Like little Paul Revere's telling those tissue systems, listen for the insulin. Listen for the insulin. Wow. And that way the dog doesn't have this huge glut of insulin flowing all over its body, accelerating its aging processes, causing inflammation, et cetera, et cetera.

[B]

Yeah. So where is this pill at? Like, so the FDA has to approve the drug. When can we expect to see it available for people to use for their dogs?

[C]

Yeah. So there are three kind of main prongs of conditional approval at the fda, and they are efficacy, which is like, does the thing work? Manufacturing, can you make it in a reproducible way? And then safety. And right now, Loyal has had the efficacy and safety. They have conditional approval for both of those. So they're only waiting on manufacturing. And I don't. Manufacturing drugs is super complicated, and I don't want to trivialize it, but of those three, that's like, the right one to be outstanding. Like, I think that's a hurdle they're going to get over. And so it's looking like the pill will be available early next year.

[B]

Oh, wow, that's soon.

[C]

Yeah. And in the meantime, they're running a clinical trial that is going to take, you know, another four or five years for final approval, but they can sell it with conditional approval starting probably next year.

[B]

So, you know, I have a personal question. This is being focused on dogs, but why not cats? I have four cats. And are there pills for cats?

[C]

You know, I know that there are some cat longevity startups So I have that good news to report to you. But I will say that one reason that I think dogs may have edged out cats as, like, the first kind of sample animal for this is they just are. It's easier to get them to take a pill.

[B]

I think you're right. My cats won't take pills. I thought it was going to be because cats live longer, but I think you're right.

[C]

Yeah.

[B]

So dogs are better at taking pills. Do the dogs. Do they like it? Is it okay?

[C]

Yeah. Well, I'll tell you what. Dogs are better at taking pills, but they're not perfect. And because this is going to be a daily pill that they will take for literally the rest of their lives, Loyal actually put together a focus group of, like, 20 taste tester dogs to get the flavor right, and it was interesting. They couldn't just do it one day because dogs will just, like, chomp down anything the first time. Right, Right. So they had to do multiple days, and some of the dogs were actually, like, quite discerning. In fact, one of them spat out one of the flavors they didn't like and ended up peeing on it.

[B]

Oh, my gosh. What are the flavors?

[C]

I think it's a beef flavored is what they ended up settling on.

[B]

If it was cats, it would be seafood.

[C]

There you go.

[B]

Okay, so this is maybe the most important question for you. I know you have a dog at home. His name is Forrest, right?

[C]

I do. Forest is. He's actually sleeping at my feet right now.

[B]

Aw. So if this pill gets approved, are you planning to give it to your dog?

[C]

Yeah. Well, so Forrest is 4 years old, so he's in a little bit of a sweet spot because the clinical trial to see, like, if and how well this thing works to, like, very high precision will be done by the time he's eligible. Dogs are eligible at 10 years old.

[B]

Wow. You're ready.

[C]

Yeah. And if they pass with flying colors, I'll absolutely give it to him.

[B]

Oh, my gosh.

[C]

I want him around longer.

[B]

Oh, there he is. Ross, thank you so much for talking with us. I had a great time.

[C]

Yeah, Regina, this was great. Thanks for having me on.

[B]

If you like this episode, why don't you share it with a friend that you know is obsessed with their dog? They're gonna love it, and they're gonna thank you for it. This episode was produced by Arundhati Nair. It was edited by our showrunner, Rebecca Ramirez. And Tyla Jones checked the facts. Kwesi Lee was the audio engineer. I'm Regina Barber. Thank you for listening to shortwave from npr.

[C]

How they verify the age of the dogs. I just thought it was funny that, like, some of the dogs needed Facebook photos.

[B]

What?

[C]

Yeah, because, like, people don't have, like, their dog birth certificate, so they had to, like, put like, screenshots of their Facebook posts showing that, you know, them being like, I got a new puppy, you know, and it's time stamped. That worked for age verification.

[B]

You know, you have like the old man dogs and you have like, you know, losing their sight, they're losing their hearing.

[C]

I feel like an old man dog.

[B]

I also feel like an old man dog.

[A]

This message comes from Capella University. You know that feeling when there's a spark building inside you that you were meant for more? That's your own drive pushing you towards what's next. Capella University gets that with their flexpath learning format. You can set the pace and earn your degree without putting life on pause. You've built experience and know what you're capable of. Now this is your time to turn that momentum into more. The only real question is, what can't you do? Learn more at Capella. Edu.

[B]

This message comes from Mint Mobile. If you're tired of spending hundreds on big wireless bills, bogus fees and free perks, Mint Mobile is for you. Shop [e-mail] Switch taxes and fees extra. See Mint Mobile for details.